Dopamine D4 receptors in psychostimulant addiction

Advances in Pharmacology

Volumn 69, Issue , 2014, Pages 301-321

  Di Ciano, Patricia ^a   Grandy, David K ^b   Le Foll, Bernard ^a,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Amphetamine; Cocaine; D4; Dopamine; Nicotine; Smoking

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE 4 RECEPTOR; NICOTINE;

ARTICLE; BEHAVIOR; CHEMICAL STRUCTURE; COCAINE DEPENDENCE; DRUG DEPENDENCE; DRUG DISCRIMINATION; DRUG SELF ADMINISTRATION; DRUG SENSITIZATION; GENETIC ASSOCIATION; HUMAN; MEDICAL LITERATURE; NONHUMAN; PHARMACOLOGY; PLACE PREFERENCE; PRIORITY JOURNAL; PSYCHOSTIMULANT ADDICTION; RELAPSE; REWARD; TOBACCO DEPENDENCE;

EID: 84893168199     PISSN: 10543589     EISSN: 15578925     Source Type: Book Series    
DOI: 10.1016/B978-0-12-420118-7.00008-1     Document Type: Chapter

References (98)

1. Andreoli M., Tessari M., Pilla M., Valerio E., Hagan J.J., Heidbreder C.A. Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior. Neuropsychopharmacology 2003, 28(7):1272-1280.
2. Benjamin J., Li L., Patterson C., Greenberg B.D., Murphy D.L., Hamer D.H. Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nature Genetics 1996, 12(1):81-84. 10.1038/ng0196-81.
3. Bergman J., Roof R.A., Furman C.A., Conroy J.L., Mello N.K., Sibley D.R., et al. Modification of cocaine self-administration by buspirone (buspar(R)): Potential involvement of D3 and D4 dopamine receptors. The International Journal of Neuropsychopharmacology 2013, 16(2):445-458. 10.1017/S1461145712000661.
4. Bernaerts P., Tirelli E. Facilitatory effect of the dopamine D4 receptor agonist PD168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL/6J mice. Behavioural Brain Research 2003, 142(1-2):41-52. S0166432802003716 [pii].
5. Brody A.L., Mandelkern M.A., Olmstead R.E., Scheibal D., Hahn E., Shiraga S., et al. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Archives of General Psychiatry 2006, 63(7):808-816. 63/7/808 [pii]. 10.1001/archpsyc.63.7.808.
6. 2 receptor cDNA. Nature 1988, 336:783-787.
7. Carr G.D., Fibiger H.C., Phillips A.G. Conditioned place preference as a measure of drug reward. Neuropharmacological basis of reward 1989, 264-319. New York: Oxford. J.M. Liebman, S.J. Cooper (Eds.).
8. Chang F.M., Kidd J.R., Livak K.J., Pakstis A.J., Kidd K.K. The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Human Genetics 1996, 98(1):91-101.
9. Chen C.K., Hu X., Lin S.K., Sham P.C., Loh el W., Li T., et al. Association analysis of dopamine D2-like receptor genes and methamphetamine abuse. Psychiatric Genetics 2004, 14(4):223-226. 00041444-200412000-00011 [pii].
10. Chiamulera C., Borgo C., Falchetto S., Valerio E., Tessari M. Nicotine reinstatement of nicotine self-administration after long-term extinction. Psychopharmacology 1996, 127(2):102-107.
11. Cocker P.J., Le Foll B., Rogers R.D., Winstanley C.A. A selective role for dopamine D receptors in modulating reward expectancy in a rodent slot machine task. Biological Psychiatry 2013, (in press). 10.1016/j.biopsych.2013.08.026.
12. 4 receptors coupled to adenylate cyclase. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:12093-12097.
13. Costanza R.M., Terry P. The dopamine D4 receptor antagonist L-745,870: Effects in rats discriminating cocaine from saline. European Journal of Pharmacology 1998, 345(2):129-132.
14. David S.P., Munafo M.R., Murphy M.F., Proctor M., Walton R.T., Johnstone E.C. Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: Follow-up of a randomised clinical trial of transdermal nicotine patch. The Pharmacogenomics Journal 2008, (8):122-128. 6500447 [pii]. http://dx.doi.org/10.1038/sj.tpj.6500447.
15. de Wit H., Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 1981, 75:134-143.
16. 1 dopamine receptor. Nature 1990, 347:72-76.
17. Di Ciano P., Coury A., Depoortere R.Y., Egilmez Y., Lane J.D., Emmett-Oglesby M.W., et al. Comparison of changes in extracellular dopamine concentrations in the nucleus accumbens during intravenous self-administration of cocaine or d-amphetamine. Behavioural Pharmacology 1995, 6(4):311-322.
18. Di Ciano P., Underwood R.J., Hagan J.J., Everitt B.J. Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology 2003, 28(2):329-338.
19. Dulawa S.C., Grandy D.K., Low M.J., Paulus M.P., Geyer M.A. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. The Journal of Neuroscience 1999, 19(21):9550-9556.
20. Ebstein R.P., Novick O., Umansky R., Priel B., Osher Y., Blaine D., et al. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nature Genetics 1996, 12(1):78-80.
21. Epstein D.H., Preston K.L. The reinstatement model and relapse prevention: A clinical perspective. Psychopharmacology 2003, 168(1-2):31-41.
22. Feldpausch D.L., Needham L.M., Stone M.P., Althaus J.S., Yamamoto B.K., Svensson K.A., et al. The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations. The Journal of Pharmacology and Experimental Therapeutics 1998, 286(1):497-508.
23. Forget B., Coen K.M., Le Foll B. Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration-Comparison with CB(1) receptor blockade. Psychopharmacology 2009, 205(4):613-624. 10.1007/s00213-009-1569-5.
24. Frank M.J., Fossella J.A. Neurogenetics and pharmacology of learning, motivation, and cognition. Neuropsychopharmacology 2011, 36(1):133-152. 10.1038/npp.2010.96.
25. Gal K., Gyertyan I. Targeting the dopamine D3 receptor cannot influence continuous reinforcement cocaine self-administration in rats. Brain Research Bulletin 2003, 61(6):595-601.
26. Gerber G.J., Stretch R. Drug-induced reinstatement of extinguished self-administration behavior in monkeys. Pharmacology, Biochemistry, and Behavior 1975, 3(6):1055-1061.
27. 2 dopamine receptor isoforms. Nature 1989, 342:923-926.
28. 2 dopamine receptor. Proceedings of the National Academy of Sciences of the United States of America 1989, 84:9762-9766.
29. Grandy D.K., Zhang Y.A., Bouvier C., Zhou Q.Y., Johnson R.A., Allen L., et al. Multiple human D5 dopamine receptor genes: A functional receptor and two pseudogenes. Proceedings of the National Academy of Sciences of the United States of America 1991, 88(20):9175-9179.
30. Hutchison K.E., LaChance H., Niaura R., Bryan A., Smolen A. The DRD4 VNTR polymorphism influences reactivity to smoking cues. Journal of Abnormal Psychology 2002, 111(1):134-143.
31. Ito R., Robbins T.W., McNaughton B.L., Everitt B.J. Selective excitotoxic lesions of the hippocampus and basolateral amygdala have dissociable effects on appetitive cue and place conditioning based on path integration in a novel Y-maze procedure. The European Journal of Neuroscience 2006, 23(11):3071-3080.
32. Katz J.L., Chausmer A.L., Elmer G.I., Rubinstein M., Low M.J., Grandy D.K. Cocaine-induced locomotor activity and cocaine discrimination in dopamine D4 receptor mutant mice. Psychopharmacology 2003, 170(1):108-114.
33. Keck T.M., Suchland K.L., Jimenez C.C., Grandy D.K. Dopamine D4 receptor deficiency in mice alters behavioral responses to anxiogenic stimuli and the psychostimulant methylphenidate. Pharmacology, Biochemistry, and Behavior 2013, 103(4):831-841. 10.1016/j.pbb.2012.12.006.
34. Khaled M.A., Farid Araki K., Li B., Coen K.M., Marinelli P.W., Varga J., et al. The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking. The International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum 2010, 13(2):181-190. S1461145709991064 [pii]. 10.1017/S1461145709991064.
35. Koffarnus M.N., Collins G.T., Rice K.C., Chen J., Woods J.H., Winger G. Self-administration of agonists selective for dopamine D2, D3, and D4 receptors by rhesus monkeys. Behavioural Pharmacology 2012, 23(4):331-338. 10.1097/FBP.0b013e3283564dbb.
36. Koob G.F. Neural mechanisms of drug reinforcement. Annals of the New York Academy of Sciences 1992, 654:171-191.
37. Kuczenski R., Segal D. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. The Journal of Neuroscience 1989, 9(6):2051-2065.
38. Kulagowski J.J., Broughton H.B., Curtis N.R., Mawer I.M., Ridgill M.P., Baker R., et al. 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: An antagonist with high affinity and selectivity for the human dopamine D4 receptor. Journal of Medicinal Chemistry 1996, 39(10):1941-1942. 10.1021/jm9600712.
39. Kuntsi J., McLoughlin G., Asherson P. Attention deficit hyperactivity disorder. Neuromolecular Medicine 2006, 8(4):461-484. 10.1385/NMM:8:4:461.
40. Laucht M., Becker K., El-Faddagh M., Hohm E., Schmidt M.H. Association of the DRD4 exon III polymorphism with smoking in fifteen-year-olds: A mediating role for novelty seeking?. Journal of the American Academy of Child and Adolescent Psychiatry 2005, 44(5):477-484.
41. Le Foll B., Boileau I. Repurposing buspirone for drug addiction treatment. The International Journal of Neuropsychopharmacology 2013, 16(2):251-253. 10.1017/S1461145712000995.
42. Le Foll B., Gallo A., Le Strat Y., Lu L., Gorwood P. Genetics of dopamine receptors and drug addiction: A comprehensive review. Behavioural Pharmacology 2009, 20(1):1-17. 10.1097/FBP.0b013e3283242f05.
43. Le Foll B., Goldberg S.R. Targeting the dopamine D3 receptor for treatment of tobacco dependence. Medication treatments for nicotine dependence 2006, Taylor and Francis, London. T.P. George (Ed.).
44. 4 (DRD4) gene. Human Molecular Genetics 1993, 2:767-773.
45. Liu Y., Le Foll B., Wang X., Lu L. Conditioned place preference induced by licit drugs: Establishment, extinction, and reinstatement. Scientific World Journal 2008, 8:1228-1245. 10.1100/tsw.2008.154.
46. Malhotra A.K., Virkkunen M., Rooney W., Eggert M., Linnoila M., Goldman D. The association between the dopamine D4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty seeking. Molecular Psychiatry 1996, 1(5):388-391.
47. Mascia P., Pistis M., Justinova Z., Panlilio L.V., Luchicchi A., Lecca S., et al. Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors. Biological Psychiatry 2011, 69(7):633-641. S0006-3223(10)00716-X [pii]. 10.1016/j.biopsych.2010.07.009.
48. McClernon F.J., Hutchison K.E., Rose J.E., Kozink R.V. DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues. Psychopharmacology 2007, 194(4):433-441. 10.1007/s00213-007-0860-6.
49. McGeary J. The DRD4 exon 3 VNTR polymorphism and addiction-related phenotypes: A review. Pharmacology, Biochemistry, and Behavior 2009, 93(3):222-229. 10.1016/j.pbb.2009.03.010.
50. McKee S.A. Developing human laboratory models of smoking lapse behavior for medication screening. Addiction Biology 2009, 14(1):99-107. 10.1111/j.1369-1600.2008.00135.x.
51. Meador-Woodruff J.H., Grandy D.K., Van Tol H.H.M., Damask S.P., Little K.Y., Civelli O., et al. Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology 1994, 10:239-248.
52. Meador-Woodruff J.H., Haroutunian V., Powchik P., Davidson M., Davis K.L., Watson S.J. Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Archives of General Psychiatry 1997, 54:1089-1095.
53. Merchant K.M., Gill G.S., Harris D.W., Huff R.M., Eaton M.J., Lookingland K., et al. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist. The Journal of Pharmacology and Experimental Therapeutics 1996, 279(3):1392-1403.
54. 1 dopamine receptor linked to adenylyl cyclase activation. Proceedings of the National Academy of Sciences of the United States of America 1991, 87:6723-6727.
55. Mrzljak L., Bergson C., Pappy M., Huff R., Levenson R., Goldman-Rakic P.S. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 1996, 381(6579):245-248. 10.1038/381245a0.
56. Munafo M.R., Johnstone E.C. Smoking status moderates the association of the dopamine D4 receptor (DRD4) gene VNTR polymorphism with selective processing of smoking-related cues. Addiction Biology 2008, 13(3-4):435-439. ADB098 [pii]. 10.1111/j.1369-1600.2008.00098.x.
57. 4 receptor sequence, gene structure, and demonstration of expression in the cardiovascular system. The New Biologist 1992, 2:137-146.
58. Pettit H.O., Justice J.B. Effect of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens. Brain Research 1991, 539(1):94-102.
59. Pickens R., Thompson T. Cocaine-reinforced behavior in rats: Effects of reinforcement magnitude and fixed-ratio size. The Journal of Pharmacology and Experimental Therapeutics 1968, 161(1):122-129.
60. Powell S.B., Paulus M.P., Hartman D.S., Godel T., Geyer M.A. RO-10-5824 is a selective dopamine D4 receptor agonist that increases novel object exploration in C57 mice. Neuropharmacology 2003, 44(4):473-481.
61. Ptacek R., Kuzelova H., Stefano G.B. Dopamine D4 receptor gene DRD4 and its association with psychiatric disorders. Medical Science Monitor 2011, 17(9):RA215-RA220. [Review].
62. Pushparaj A., Hamani C., Yu W., Shin D.S., Kang B., Nobrega J.N., et al. Electrical stimulation of the insular region attenuates nicotine-taking and nicotine-seeking behaviors. Neuropsychopharmacology 2013, 38(4):690-698. npp2012235 [pii]. 10.1038/npp.2012.235.
63. Ralph R.J., Varty G.B., Kelly M.A., Wang Y.M., Caron M.G., Rubinstein M., et al. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. The Journal of Neuroscience 1999, 19(11):4627-4633.
64. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Research Reviews 1986, 11:157-198.
65. Robinson T.E., Berridge K.C. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research Reviews 1993, 18:247-291.
66. Rondou P., Haegeman G., Van Craenenbroeck K. The dopamine D4 receptor: Biochemical and signalling properties. Cellular and Molecular Life Sciences 2010, 67(12):1971-1986. 10.1007/s00018-010-0293-y.
67. Rubinstein M., Phillips T.J., Bunzow J.R., Falzone T.L., Dziewczapolski G., Zhang G., et al. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 1997, 90(6):991-1001.
68. Schoots O., Van Tol H.H. The human dopamine D4 receptor repeat sequences modulate expression. The Pharmacogenomics Journal 2003, 3(6):343-348. 6500208 [pii]. 10.1038/sj.tpj.6500208.
69. Schultz W. Behavioral theories and the neurophysiology of reward. Annual Review of Psychology 2006, 57:87-115.
70. Seeman P., Van Tol H.H. Dopamine receptor pharmacology. Trends in Pharmacological Sciences 1994, 15(7):264-270.
71. Shaham Y., Adamson L.K., Grocki S., Corrigall W.A. Reinstatement and spontaneous recovery of nicotine seeking in rats. Psychopharmacology 1997, 130(4):396-403.
72. Shields P.G., Lerman C., Audrain J., Bowman E.D., Main D., Boyd N.R., et al. Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. Cancer Epidemiology, Biomarkers and Prevention 1998, 7:453-458.
73. 3) as a target for neuroleptics. Nature 1990, 347(6289):146-151.
74. Stretch R., Gerber G.J. Drug-induced reinstatement of amphetamine self-administration behaviour in monkeys. Canadian Journal of Psychology 1973, 27(2):168-177.
75. 1. Nature 1991, 350:614-619.
76. 1 receptor encoded by an intronless gene on chromosome 5. Nature 1990, 347:80-83.
77. Thanos P., Bermeo C., Rubinstein M., Suchland K., Wang G., Grandy D., et al. Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors. Journal of Psychopharmacology 2010, (24):897-904. 0269881109102613 [pii]. http://dx.doi.org/10.1177/0269881109102613.
78. Thanos P.K., Habibi R., Michaelides M., Patel U.B., Suchland K., Anderson B.J., et al. Dopamine D4 receptor (D4R) deletion in mice does not affect operant responding for food or cocaine. Behavioral Brain Research 2010, 207(2):508-511. S0166-4328(09)00628-7 [pii]. 10.1016/j.bbr.2009.10.020.
79. Thomas T.C., Kruzich P.J., Joyce B.M., Gash C.R., Suchland K., Surgener S.P., et al. Dopamine D4 receptor knockout mice exhibit neurochemical changes consistent with decreased dopamine release. Journal of Neuroscience Methods 2007, 166(2):306-314. 10.1016/j.jneumeth.2007.03.009.
80. Ton T.G., Rossing M.A., Bowen D.J., Srinouanprachan S., Wicklund K., Farin F.M. Genetic polymorphisms in dopamine-related genes and smoking cessation in women: A prospective cohort study. Behavioral and Brain Functions 2007, 3:22.
81. Tsai S.J., Cheng C.Y., Shu L.R., Yang C.Y., Pan C.W., Liou Y.J., et al. No association for D2 and D4 dopamine receptor polymorphisms and methamphetamine abuse in Chinese males. Psychiatric Genetics 2002, 12(1):29-33.
82. Valerio A., Belloni M., Gorno M.L., Tinti C., Memo M., Spano P. Dopamine D2, D3, and D4 receptor mRNA levels in rat brain and pituitary during aging. Neurobiology of Aging 1994, 15(6):713-719.
83. Van Craenenbroeck K., Borroto-Escuela D.O., Romero-Fernandez W., Skieterska K., Rondou P., Lintermans B., et al. Dopamine D4 receptor oligomerization-Contribution to receptor biogenesis. The FEBS Journal 2011, 278(8):1333-1344. 10.1111/j.1742-4658.2011.08052.x.
84. Van Tol H.H., Bunzow J.R., Guan H.C., Sunahara R.K., Seeman P., Niznik H.B., et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 1991, 350(6319):610-614. 10.1038/350610a0.
85. 4 receptor variants in the human population. Nature 1992, 358:149-152.
86. Vandenbergh D.J., O'Connor R.J., Grant M.D., Jefferson A.L., Vogler G.P., Strasser A.A., et al. Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors. Addiction Biology 2007, 12(1):106-116.
87. Waddington J.L., O'Tuathaigh C., O'Sullivan G., Tomiyama K., Koshikawa N., Croke D.T. Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: Insights and challenges from 10 years at the psychopharmacology-molecular biology interface. Psychopharmacology 2005, 181(4):611-638. 10.1007/s00213-005-0058-8.
88. Wells T.T., Beevers C.G., Knopik V.S., McGeary J.E. Dopamine D4 receptor gene variation is associated with context-dependent attention for emotion stimuli. The International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum 2013, 16(3):525-534. 10.1017/S1461145712000478.
89. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychological Review 1987, 94:469-492.
90. Woolley M.L., Waters K.A., Reavill C., Bull S., Lacroix L.P., Martyn A.J., et al. Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat. Behavioural Pharmacology 2008, 19(8):765-776. 00008877-200812000-00002 [pii]. 10.1097/FBP.0b013e32831c3b06.
91. Woolverton W.L. Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacology, Biochemistry, and Behavior 1986, 24(3):531-535. 0091-3057(86)90553-8 [pii].
92. Xi Z.X., Gilbert J.G., Pak A.C., Ashby C.R., Heidbreder C.A., Gardner E.L. Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats. The European Journal of Neuroscience 2005, 21(12):3427-3438.
93. Yan Y., Nitta A., Mizuno T., Nakajima A., Yamada K., Nabeshima T. Discriminative-stimulus effects of methamphetamine and morphine in rats are attenuated by cAMP-related compounds. Behavioural Brain Research 2006, 173(1):39-46. 10.1016/j.bbr.2006.05.029.
94. Yan Y., Pushparaj A., Gamaleddin I., Steiner R.C., Picciotto M.R., Roder J., et al. Nicotine-taking and nicotine-seeking in C57Bl/6J mice without prior operant training or food restriction. Behavioural Brain Research 2012, 230(1):34-39. 10.1016/j.bbr.2012.01.042.
95. Yan Y., Pushparaj A., Le Strat Y., Gamaleddin I., Barnes C., Justinova Z., et al. Blockade of dopamine d4 receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats. Neuropsychopharmacology 2012, 37(3):685-696. 10.1038/npp.2011.245.
96. Yokel R.A., Pickens R. Drug level of d- and l-amphetamine during intravenous self-administration. Psychopharmacologia 1974, 34(3):255-264.
97. Yokel R.A., Wise R.A. Increased lever pressing for amphetamine after pimozide in rats: Implications for a dopamine theory of reward. Science 1975, 187(4176):547-549.
98. 1 dopamine receptors. Nature 1990, 347:76-86.